- American Express increased its full-year EPS forecast to $13.30-$13.80, up from the previous estimate of $12.65-$13.15.
- Revenue growth forecast remains strong at 9%-11%.
- Second quarter results show discount revenue at $8.86 billion, slightly below the estimate of $8.94 billion.
- Provision for credit losses stood at $1.3 billion.
- Total expenses were reported at $11.28 billion, which is lower than the estimated $12.11 billion.
- Card rewards expenses were $4.23 billion, just below the estimate of $4.28 billion.
- Analyst ratings: 16 buys, 13 holds, and 5 sells.
A look at American Express Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores for American Express Co, the company’s overall outlook appears to be promising for long-term investors. With solid scores in Growth, Resilience, and Momentum, American Express Co seems well-positioned to continue its success in the payment and travel sector. A strong Growth score indicates the potential for increased market share and profitability over time, while high scores in Resilience and Momentum suggest stability and positive market momentum for the company.
American Express Co, a global payment and travel company, offers charge and credit card products along with travel-related services to consumers and businesses worldwide. Despite some average scores in Value and Dividend factors, the company’s strengths in Growth, Resilience, and Momentum could make it an attractive investment option for those looking for long-term growth opportunities in the payment industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
